Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

NCT04695769 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

281

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
DRUG: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]

Sponsor

Helwan University